- Resources
- Mentoring
- Getting Involved
- ATS Reading List
- ATS Reading List
- ATS Reading List
- ARDS
- Asthma
- Bronchiectasis (Non-Cystic Fibrosis)
- Cardiology Critical Care
- COPD
- Cough
- Cystic Fibrosis
- Drug Induced Lung Disease
- End of Life Care in the ICU
- Endocrine Critical Care
- Gastroenterology Critical Care
- ICU Administration
- Immunocompromised Host
- Infection Control
- Interstitial Lung Disease
- Lung Cancer/Solitary Pulmonary Nodule
- Lung Transplantation
- Mycobacterial Diseases
- Nephrology Critical Care
- Neurology Critical Care
- Nutrition in Critical Illness
- Obstetrics and Critical Care
- Occupational and Environmental Medicine
- Pleural Diseases
- Pneumonia
- Procedures
- Pulmonary Embolism
- Pulmonary Function Testing
- Pulmonary Hypertension
- Sedation / Analgesia / Delirium
- Sepsis / Septic Shock
- Sleep Medicine
- Smoking Cessation
- Transfusion in Critical Care
- Ultrasound in the ICU
- Ventilation and Weaning
- Palliative Care
- Training Programs
Residents and Medical Students
Intensive insulin therapy
van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354:449-61. RCT of 1200 MICU patients found those randomized to intense therapy had reduced risk of acute renal injury and shorter duration of ICU stay, but no difference in mortality. Of note, patients with ICU stays < 3 days had higher mortality than controls while those with stays > 3 days had reduced mortality with intensive control.
PMID: 16452557
Free Full Text
Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-97. The NICE-SUGAR trial randomized 6,104 MICU and SICU patients with anticipated ICU stay of > 3 days to tight (81 – 108 mg/dl) or conventional (144 - 180 mg/dl) glucose control and found 90-day mortality of 27.5% with tight control vs. 24.9% with conventional (p = 0.02). The groups did not differ in secondary outcomes including duration of hospital and ICU stay or need for dialysis. In contrast, the van den Berghe studies targeted a glucose of under 215 mg/dl in the control group, had greater use of parenteral nutrition, and were performed at a single center.
PMID: 19318384
Free Full Text
